Cited by 146Acute Myeloid Leukemia ResearchCancer-related Molecular PathwaysRNA Research and Splicing

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies

Open access

Gallardo, Miguel, Lee, Hun Ju, Zhang, Xiaorui, Bueso-Ramos, Carlos, Pageon, Laura R., McArthur, Mark, Multani, Asha, Nazha, Aziz, Manshouri, Taghi, Parker-Thornburg, Jan, Rapado, Inmaculada, Quintas-Cardama, Alfonso, Kornblau, Steven M., Martinez-Lopez, Joaquin, Post, Sean M.·2015·Cancer Cell

DOI 10.1016/j.ccell.2015.09.001PMC PMC4652598

Open this paper in CoChat — free account Open PDF

Abstract

hnRNP K regulates cellular programs, and changes in its expression and mutational status have been implicated in neoplastic malignancies. To directly examine its role in tumorigenesis, we generated a mouse model harboring an Hnrnpk knockout allele (Hnrnpk(+/-)). Hnrnpk haploinsufficiency resulted in reduced survival, increased tumor formation, genomic instability, and the development of transplantable hematopoietic neoplasms with myeloproliferation. Reduced hnRNP K expression attenuated p21 activation, downregulated C/EBP levels, and activated STAT3 signaling. Additionally, analysis of samples from primary acute myeloid leukemia patients harboring a partial deletion of chromosome 9 revealed a significant decrease in HNRNPK expression. Together, these data implicate hnRNP K in the development of hematological disorders and suggest hnRNP K acts as a tumor suppressor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2015.09.001

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage
Moumen, A., Masterson, P., O'Connor, M. J., & Jackson, S. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.032 · Cited by 350
Retracted
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Couedic, J. P. L., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslová, H., Berger, R., Griscelli, A. B., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,542
Hematopoietic stem cell: self‐renewal versus differentiation
Seita, J., & Weissman, I. L. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.86 · Cited by 997
Therapeutic Advances in Acute Myeloid Leukemia
Burnett, A. K., Wetzler, M., & Löwenberg, B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1820 · Cited by 806
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?
Mrózek, K., Marcucci, G., Paschka, P., Whitman, S. P., & Bloomfield, C. D. (2006) · Blood · doi:10.1182/blood-2006-06-001149 · Cited by 554
mRNA Silencing in Erythroid Differentiation: hnRNP K and hnRNP E1 Regulate 15-Lipoxygenase Translation from the 3′ End
Ostareck, D. H., Ostareck‐Lederer, A., Wilm, M. S., Thiele, B. J., Mann, M., & Hentze, M. W. (1997) · Cell · doi:10.1016/s0092-8674(00)80241-x · Cited by 502
Cooperating gene mutations in acute myeloid leukemia: a review of the literature
Renneville, A., Roumier, C., Biggio, V., Nibourel, O., Boissel, N., Fenaux, P., & Preudhomme, C. (2008) · Leukemia · doi:10.1038/leu.2008.19 · Cited by 362

Show all 36 references

Sorted by citations

The hnRNP family: insights into their role in health and disease
Geuens, T., Bouhy, D., & Timmerman, V. (2016) · Human Genetics · doi:10.1007/s00439-016-1683-5 · Cited by 1,096
RNA-Binding Proteins in Cancer: Old Players and New Actors
Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 774
RNA splicing factors as oncoproteins and tumour suppressors
Dvinge, H., Kim, E. H., Abdel-Wahab, O. I., & Bradley, R. K. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.51 · Cited by 702
RNA splicing dysregulation and the hallmarks of cancer
Bradley, R. K., & Anczuków, O. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00541-7 · Cited by 579
Alternative splicing and cancer: a systematic review
Zhang, Y., Qian, J., Gu, C., & Yang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00486-7 · Cited by 540
Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Urbanski, L. M., Leclair, N. K., & Anczuków, O. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1476 · Cited by 393
Splicing-factor alterations in cancers
Anczuków, O., & Krainer, A. R. (2016) · RNA · doi:10.1261/rna.057919.116 · Cited by 304
Alternative mRNA splicing in cancer immunotherapy
Frankiw, L., Baltimore, D., & Li, G. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0195-7 · Cited by 252
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
Marabti, E. E., & Younis, I. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00080 · Cited by 223
RNA Splicing and Disease: Animal Models to Therapies
Montes, M., Sanford, B. L., Comiskey, D. F., & Chandler, D. S. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.10.002 · Cited by 224
RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia
Cheng, J. X., Chen, L., Li, Y., Cloe, A., Yue, M., Wei, J., Watanabe, K. A., Shammo, J. M., Anastasi, J., Shen, Q. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03513-4 · Cited by 204
Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancer
Mohibi, S., Chen, X., & Zhang, J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.07.001 · Cited by 207
The emerging roles of hnRNPK
Wang, Z., Qiu, H., He, J., Liu, L., Xue, W., Fox, A. H., Tickner, J. C., & Xu, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29186 · Cited by 187
Xist Deletional Analysis Reveals an Interdependency between Xist RNA and Polycomb Complexes for Spreading along the Inactive X
Colognori, D., Sunwoo, H., Kriz, A. J., Wang, C., & Lee, J. T. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.01.015 · Cited by 177
Novel players in X inactivation: insights into Xist-mediated gene silencing and chromosome conformation
da Rocha, S. T., & Heard, É. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3370 · Cited by 140
The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription
Xia, A., Yuan, W., Wang, Q., Xu, J., Gu, Y., Zhang, L., Chen, C., Wang, Z., Wu, D., He, Q., et al. (2022) · Nature Cancer · doi:10.1038/s43018-021-00315-4 · Cited by 123
Aberrant hnRNP K expression: All roads lead to cancer
Gallardo, M., Aitken, M. J. L., Zhang, X., Hu, P. C., Bueso-Ramos, C., & Post, S. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1164372 · Cited by 107
Self-citation
Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics
Qiu, P., Zhou, Y., Oyang, L., Wu, N., Tang, Y., Su, M., Luo, X., Wang, Y., Sheng, X., Ma, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.11.010 · Cited by 109
MYC protein expression is an important prognostic factor in acute myeloid leukemia
Ohanian, M. N., Rozovski, U., Kanagal‐Shamanna, R., Abruzzo, L. V., Loghavi, S., Kadia, T. M., Futreal, P. A., Bhalla, K. N., Zuo, Z., Huh, Y. O., et al. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1464158 · Cited by 95
Self-citation
PROX1 promotes breast cancer invasion and metastasis through WNT/β-catenin pathway via interacting with hnRNPK
Zhu, L., Tian, Q., Gao, H., Wu, K., Wang, B., Ge, G., Jiang, S., Wang, K., Zhou, C., He, J., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68960 · Cited by 78
Targeting splicing abnormalities in cancer
Agrawal, A. A., Yu, L., Smith, P. G., & Buonamici, S. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.10.010 · Cited by 78
Genomic analysis reveals recurrent deletion of JAK‐STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides
Torres, A. N. B., Cats, D., Mei, H., Szuhai, K., Willemze, R., Vermeer, M. H., & Tensen, C. P. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22679 · Cited by 73
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?
Taìana, E., Ronchetti, D., Todoerti, K., Nobili, L., Tassone, P., Amodio, N., & Neri, A. (2020) · Non-Coding RNA · doi:10.3390/ncrna6030026 · Cited by 76
The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data
Muelas, M. W., Mughal, F., O’Hagan, S., Day, P. J., & Kell, D. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-54288-7 · Cited by 67
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia
Alanazi, B., Munje, C. R., Rastogi, N., Williamson, A. J. K., Taylor, S., Hole, P. S., Hodges, M., Doyle, M., Baker, S., Gilkes, A. F., et al. (2020) · Leukemia · doi:10.1038/s41375-019-0596-4 · Cited by 64
The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
Cerasuolo, A., Buonaguro, L., Buonaguro, L., & Tornesello, M. L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00474 · Cited by 71
LINC01413/hnRNP-K/ZEB1 Axis Accelerates Cell Proliferation and EMT in Colorectal Cancer via Inducing YAP1/TAZ1 Translocation
Ji, L., Li, X., Zhou, Z., Zheng, Z., Jin, L., & Jiang, F. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.027 · Cited by 60
RNA-Binding Proteins in Acute Leukemias
Schuschel, K., Helwig, M., Hüttelmaier, S., Heckl, D., Klusmann, J., & Hoell, J. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103409 · Cited by 57
HNRNPK maintains epidermal progenitor function through transcription of proliferation genes and degrading differentiation promoting mRNAs
Li, J., Chen, Y., Xu, X., Jones, J., Tiwari, M., Ling, J., Wang, Y., Harismendy, O., & Sen, G. L. (2019) · Nature Communications · doi:10.1038/s41467-019-12238-x · Cited by 55
LCDR regulates the integrity of lysosomal membrane by hnRNP K–stabilized LAPTM5 transcript and promotes cell survival
Yang, X., Wen, Y., Liu, S., Duan, L., Liu, T., Tong, Z., Wang, Z., Gu, Y., Xi, Y., Wang, X., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110428119 · Cited by 53
Allelic imbalance of somatic mutations in cancer genomes and transcriptomes
Rhee, J., Lee, S., Park, W., Kim, Y.-H., & Kim, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-01966-z · Cited by 47
hnRNPK recognition of the B motif of Xist and other biological RNAs
Nakamoto, M. Y., Lammer, N. C., Batey, R., & Wuttke, D. S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa677 · Cited by 46
Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice
Liu, T.-Y., Chen, Y., Jong, Y., Tsai, H., Lee, C., Chang, Y., Chang, J.-G., & Chang, Y.-F. (2017) · Open Biology · doi:10.1098/rsob.160303 · Cited by 45
hnRNPK promotes gastric tumorigenesis through regulating CD44E alternative splicing
Peng, W.-Z., Liu, J.-X., Li, C., Ma, R., & Jie, J. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1020-x · Cited by 45
Splicing dysregulation in cancer: from mechanistic understanding to a new class of therapeutic targets
Wang, Y., Bao, Y., Zhang, S., & Wang, Z. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1605-0 · Cited by 44
Phenotypic spectrum of Au–Kline syndrome: a report of six new cases and review of the literature
Au, P. Y. B., Goedhart, C., Ferguson, M., Breckpot, J., Devriendt, K., Wierenga, K. J., Fanning, E., Grange, D. K., Graham, G. E., Galarreta, C. I., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0187-2 · Cited by 41
Harnessing host–virus evolution in antiviral therapy and immunotherapy
Heaton, S. M. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1067 · Cited by 42
Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
Kitamura, K., & Nimura, K. (2021) · Cells · doi:10.3390/cells10040923 · Cited by 38
Comprehensive network of miRNA-induced intergenic interactions and a biological role of its core in cancer
Galatenko, V., Galatenko, A. V., Samatov, T. R., Turchinovich, A. A., Shkurnikov, M. Y., Makarova, J. A., & Tonevitsky, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-20215-5 · Cited by 40
Induction of Senescence in Cancer Cells by a Novel Combination of Cucurbitacin B and Withanone: Molecular Mechanism and Therapeutic Potential
Garg, S., Huifu, H., Kumari, A., Sundar, D., Kaul, S. C., & Wadhwa, R. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz077 · Cited by 39
Cancer‐associated mutations in VAV1 trigger variegated signaling outputs and T‐cell lymphomagenesis
Robles‐Valero, J., Fernández‐Nevado, L., Lorenzo‐Martín, L. F., Cuadrado, M., Fernández‐Pisonero, I., Rodríguez‐Fdez, S., Astorga‐Simón, E. N., Abad, A., Caloto, R., & Bustelo, X. R. (2021) · The EMBO Journal · doi:10.15252/embj.2021108125 · Cited by 36
SKI controls MDS-associated chronic TGF-β signaling, aberrant splicing, and stem cell fitness
Muench, D. E., Ferchen, K., Velu, C. S., Pradhan, K., Chetal, K., Chen, X., Weirauch, M. T., Colmenares, C., Verma, A. K., Salomonis, N., et al. (2018) · Blood · doi:10.1182/blood-2018-06-860890 · Cited by 35
Uncovering the Role of RNA-Binding Protein hnRNP K in B-Cell Lymphomas
Gallardo, M., Malaney, P., Aitken, M. J. L., Zhang, X., Link, T. M., Shah, V. V., Alybayev, S., Wu, M., Pageon, L. R., Ma, H., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz078 · Cited by 36
Self-citation
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia
Post, S. M., Ma, H., Malaney, P., Zhang, X., Aitken, M. J. L., Mak, P. Y., Ruvolo, V. R., Yasuhiro, T., Kozaki, R., Chan, L. E., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278369 · Cited by 33
Self-citation
Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape
Sudhakaran, M., & Doseff, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065086 · Cited by 31
HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway
Huang, H., Han, Y. K., Yang, X., Li, M., Zhu, R., Hu, J., Zhang, X., Wei, R., Li, K., & Gao, R. (2017) · Oncotarget · doi:10.18632/oncotarget.21873 · Cited by 30
Self-citation
FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis
Wu, L., Zhu, X., Song, Z., Guo, M., Liang, J., & Yan, D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117998 · Cited by 29
Regulation of HNRNP family by post-translational modifications in cancer
Li, B., Wen, M., Gao, F., Wang, Y., Wei, G., & Duan, Y. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02198-7 · Cited by 28
A biophysical basis for the spreading behavior and limited diffusion of Xist
Ding, M., Wang, D., Chen, H., Kesner, B., Grimm, N.-B., Weissbein, U., Lappala, A., Jiang, J., Rivera, C., Lou, J., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.004 · Cited by 33
KH-Domain Poly(C)-Binding Proteins as Versatile Regulators of Multiple Biological Processes
Nazarov, I. B., Bakhmet, E. I., & Tomilin, A. N. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919030039 · Cited by 27
A tumor-specific modulation of heterogeneous ribonucleoprotein A0 promotes excessive mitosis and growth in colorectal cancer cells
Konishi, H., Fujiya, M., Kashima, S., Sakatani, A., Dokoshi, T., Ando, K., Ueno, N., Iwama, T., Moriichi, K., Tanaka, H., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2439-7 · Cited by 29
HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia
Liu, M., Yang, L., Liu, X., Nie, Z.-Y., Zhang, X., Lu, Y., Pan, Y., Wang, X., & Luo, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682859 · Cited by 27
Self-citation
Deletion of Hnrnpk Gene Causes Infertility in Male Mice by Disrupting Spermatogenesis
Xu, H., Guo, J., Wu, W., Qiu, H., Huang, Y., Wang, Y., Li, C., Cheng, X., Zhang, P., & Xu, Y. (2022) · Cells · doi:10.3390/cells11081277 · Cited by 27
HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction
Li, Y., Yang, Y., Ma, Q., Cheng, H., Wang, H., Ma, C., Li, F., Zhao, S., Li, X., Qi, Y., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.76083 · Cited by 26
The multifunctional RNA-binding protein hnRNPK is critical for the proliferation and differentiation of myoblasts
Xu, Y., Li, R., Zhang, K., Wu, W., Wang, S., Zhang, P., & Xu, H. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.7.043 · Cited by 25
Whole‐genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm
Torres, A. N. B., Cats, D., Mei, H., Fanoni, D., Gliozzo, J., Corti, L., Paulli, M., Vermeer, M. H., Willemze, R., Berti, E., et al. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22831 · Cited by 24
Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translation
Mucha, B., Qie, S., Bajpai, S., Tarallo, V., Diehl, J. N., Tedeschi, F., Zhou, G., Gao, Z., Flashner, S., Klein-Szanto, A. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34402-6 · Cited by 23
Post-transcriptional regulation in hematopoiesis: RNA binding proteins take control
de Rooij, L. P. M. H., Chan, D. C. H., Chahi, A. K., & Hope, K. J. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0310 · Cited by 23
Connecting Versatile lncRNAs with Heterogeneous Nuclear Ribonucleoprotein K and Pathogenic Disorders
Zhu, S., Wang, Z., & Xu, J. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.06.001 · Cited by 23
The B-side of Xist
Monfort, A., & Wutz, A. (2020) · F1000Research · doi:10.12688/f1000research.21362.1 · Cited by 20
Introduction to Epigenetics
Paro, R., Grossniklaus, U., Santoro, R., & Wutz, A. (2021) · Learning materials in biosciences · doi:10.1007/978-3-030-68670-3 · Cited by 26
The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal Adenocarcinoma
Li, Y., Wang, H., Wan, J., Ma, Q., Qi, Y., & Gu, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.845931 · Cited by 20
Comprehensive Analysis of the Functions and Prognostic Value of RNA-Binding Proteins in Thyroid Cancer
Ma, Y., Yin, S., Liu, X., Hu, J. R., Cai, N., Zhang, X.-B., Fu, L., Cao, X., & Yu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.625007 · Cited by 18
Self-citation
Characterization of acute myeloid leukemia with del(9q) – Impact of the genes in the minimally deleted region
Vries, I. S. N., Sackmann, Y., Klein, F., Ostareck‐Lederer, A., Ostareck, D. H., Jost, E., Ehninger, G., Brümmendorf, T. H., Marx, G., Röllig, C., et al. (2018) · Leukemia Research · doi:10.1016/j.leukres.2018.11.007 · Cited by 19
hnRNP-K Targets Open Chromatin in Mouse Embryonic Stem Cells in Concert with Multiple Regulators
Bakhmet, E. I., Nazarov, I. B., Gazizova, A. R., Vorobyeva, N. E., Kuzmin, A. A., Gordeev, M. N., Sinenko, S. A., Aksenov, N. D., Артамонова, Т. О., Khodorkovskii, M. A., et al. (2019) · Stem Cells · doi:10.1002/stem.3025 · Cited by 17
RNA-binding motifs of hnRNP K are critical for induction of antibody diversification by activation-induced cytidine deaminase
Yin, Z., Kobayashi, M., Hu, W., Higashi, K., Begum, N. A., Kurokawa, K., & Honjo, T. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921115117 · Cited by 19
Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias
Mäkelä, E., Pavic, K., Varila, T., Salmenniemi, U., Löyttyniemi, E., Nagelli, S. G., Ammunét, T., Kähäri, V.-M., Clark, R. E., Elo, L. L., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3679 · Cited by 18
Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy
Zhao, H., Wei, Z., Shen, G., Chen, Y., Hao, X., Li, S., & Wang, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1045797 · Cited by 17
Epigenetic Control of Cancer Cell Proliferation and Cell Cycle Progression by HNRNPK via Promoting Exon 4 Inclusion of Histone Code Reader SPIN1
Li, D., Guo, J., & Jia, R. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.167993 · Cited by 17
From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform
Tian, N., Li, J., Shi, J., & Sui, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030191 · Cited by 17
Tubular Deficiency of Heterogeneous Nuclear Ribonucleoprotein F Elevates Systolic Blood Pressure and Induces Glycosuria in Mice
Lo, C., Miyata, K. N., Zhao, S., Ghosh, A., Chang, S., Chénier, I., Filep, J. G., Ingelfinger, J. R., Zhang, S., & Chan, J. S. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-52323-1 · Cited by 16
Role of heterogeneous nuclear ribonucleoprotein K in tumor development
Chen, Y., Zeng, Y., Xiao, Z. Y., Chen, S., Li, Y., Zou, J., & Zeng, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28867 · Cited by 16
The Role of RNA-Binding Proteins in Hematological Malignancies
Aguilar-Garrido, P., Otero, Á., Navarro-Aguadero, M. Á., Velasco‐Estevez, M., & Gallardo, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179552 · Cited by 15
Self-citation
Peroxiredoxin 5 regulates osteogenic differentiation through interaction with hnRNPK during bone regeneration
Cho, E., Che, X., Ang, M. J., Cheon, S., Lee, J., Kim, K. S., Lee, C. H., Lee, S.-Y., Yang, H., Moon, C., et al. (2023) · eLife · doi:10.7554/elife.80122 · Cited by 13
The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia
Wakim, J., Arman, E., Becker-Herman, S., Kramer, M. P., Bakos, E., Shachar, I., & Elson, A. (2017) · Oncogene · doi:10.1038/onc.2016.523 · Cited by 14
RNA Regulators in Leukemia and LymphomaPreprint
Prieto, C., & Kharas, M. G. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034967 · Cited by 13
Heterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via altered Runx1 splicing
Aitken, M. J. L., Malaney, P., Zhang, X., Herbrich, S. M., Chan, L., Benitez, O., Rodriguez, A., Ma, H., Jacamo, R. O., Duan, R., et al. (2022) · NAR Cancer · doi:10.1093/narcan/zcac039 · Cited by 13
Self-citation
Downregulation of HNRNPK in human cancer cells inhibits lung metastasis
Li, M., Zhang, W., Yang, X., Liu, H., Cao, L., Li, W., Wang, L., Zhang, G., & Gao, R. (2019) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12090 · Cited by 12
VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles
Cuadrado, M., & Robles‐Valero, J. (2021) · Biology · doi:10.3390/biology10090888 · Cited by 12
p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL
Lee, H. J., Gallardo, M., Ma, H., Zhang, X., Larsson, C. A., Mejia, A., Hornbaker, M., Qi, Y., Su, X., Pageon, L. R., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.41 · Cited by 13
Self-citation
The long non-coding RNA RSDR protects against acute kidney injury in mice by interacting with hnRNPK to regulate DHODH-mediated ferroptosis
Li, B., Lin, F., Song, B., Han, S., Ye, Z., Sun, Y., Wang, P., Xia, Y., Yu, W., Zhou, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62433-2 · Cited by 11
Hnrnpk is essential for embryonic limb bud development as a transcription activator and a collaborator of insulator protein Ctcf
Chen, Y., Zhou, T., Liao, Z., Gao, W., Wu, J., Zhang, S., Li, Y., Liu, H., Zhou, H., Xu, C., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01207-z · Cited by 11
Splicing machinery genomics events in acute myeloid leukaemia (AML): in search for therapeutic targets, diagnostic and prognostic biomarkers.
Dlamini, Z., Shoba, B., & Hull, R. (2020) · PubMed Central · Cited by 10
Chromatin Regulator SPEN/SHARP in X Inactivation and Disease
Giaimo, B. D., Robert-Finestra, T., Oswald, F., Gribnau, J. H., & Borggrefe, T. (2021) · Cancers · doi:10.3390/cancers13071665 · Cited by 10
Identifying novel regulators of placental development using time-series transcriptome data
Vu, H. T. H., Kaur, H., Kies, K. R., Starks, R. R., & Tuteja, G. (2022) · Life Science Alliance · doi:10.26508/lsa.202201788 · Cited by 10
Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology
Su, Y., Guo, Y., Guo, J., Zeng, T., Wang, T., & Liu, W. (2023) · BMC Genomics · doi:10.1186/s12864-023-09238-z · Cited by 9
Expression analysis of multifunctional RNA-binding protein hnRNP K during development of mammalian testis
Xu, H., Zhang, P., Li, R., Wu, W., Wang, S., & Xu, Y. (2018) · Polish Journal of Veterinary Sciences · doi:10.24425/122603 · Cited by 9
Odorant Sensory Input Modulates DNA Secondary Structure Formation and Heterogeneous Ribonucleoprotein Recruitment on the Tyrosine Hydroxylase and Glutamic Acid Decarboxylase 1 Promoters in the Olfactory Bulb
Wang, M., Cai, E., Fujiwara, N., Fones, L., Brown, E., Yanagawa, Y., & Cave, J. W. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1363-16.2017 · Cited by 9
Nucleic acid-binding KH domain proteins influence a spectrum of biological pathways including as part of membrane-localized complexes
Hasan, M. K., & Brady, L. J. (2024) · Journal of Structural Biology X · doi:10.1016/j.yjsbx.2024.100106 · Cited by 8
hnRNPK-derived cell-penetrating peptide inhibits cancer cell survival
Pavan Kumar, P., Buczkowski, S. A., & Moon, A. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.10.004 · Cited by 8
Assessing the role of intrinsic disorder in RNA-binding protein function: hnRNP K as a case study
Malaney, P., Benitez, O., Zhang, X., & Post, S. M. (2022) · Methods · doi:10.1016/j.ymeth.2022.10.009 · Cited by 8
Self-citation
Removal of Nonspecific Binding Proteins is Required in Co-Immunoprecipitation with Nuclear Proteins
Zeng, X., Zeng, W.-H., Zhou, J., Liu, X., Huang, G. C., Zhu, H. M., Xiao, S., Zeng, Y., & Cao, D. (2022) · BioTechniques · doi:10.2144/btn-2022-0048 · Cited by 8
Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse
Hoff, F. W., Hu, C. W., Qutub, A. A., Qiu, Y., Aitken, M. J. L., Bueso-Ramos, C., Abbas, H. A., Post, S. M., de Bont, E. S. J. M., & Kornblau, S. M. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800133 · Cited by 8
Self-citation
Insights into the role of hnRNPK in spermatogenesis via the piRNA pathway
Xu, H., Guo, J., Huang, Y., Zhang, M., Wang, Y., Li, X., Cheng, X., Meng, T., Hao, R., Wei, X., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-91081-1 · Cited by 7
Comprehensive characterization of the alternative splicing landscape in ovarian cancer reveals novel events associated with tumor-immune microenvironment
Sun, D., Zhao, X., Yu, Y., Li, W., Gu, P., Zhi, Z., & Xu, D. (2022) · Bioscience Reports · doi:10.1042/bsr20212090 · Cited by 7
The RNA binding protein hnRNPK protects against adriamycin-induced podocyte injury
Zhao, S., Feng, J., Li, J., Cao, R., Zhang, Y., Yang, S., & Yin, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-3577 · Cited by 6
The tumor suppressor HNRNPK induces p53-dependent nucleolar stress to drive ribosomopathies
Aguilar-Garrido, P., Velasco‐Estevez, M., Navarro-Aguadero, M. Á., Otero, Á., Ibáñez-Navarro, M., Marugal, M. Á., Hernández‐Sánchez, M., Malaney, P., Rodriguez, A., Benitez, O., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci183697 · Cited by 7
Self-citation
Recruitment of chromatin remodelers by XIST B-repeat region is variably dependent on HNRNPK
Navarro-Cobos, M. J., & Brown, C. J. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae173 · Cited by 6
Insights into the Establishment of Chromatin States in Pluripotent Cells from Studies of X Inactivation
Postlmayr, A., & Wutz, A. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.013 · Cited by 6
Activation of NLRP2 in Triple-Negative Breast Cancer sensitizes chemotherapeutic therapy through facilitating hnRNPK function
Jin, L., Li, T., Hong, Y., Mao, R., Li, X., Zhu, C., Mu, J., Zhou, J., Pan, L., Que, Y., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115703 · Cited by 6

Authors: Gallardo, M., Lee, H. J., Zhang, X., Bueso-Ramos, C., Pageon, L. R., McArthur, M., Multani, A., Nazha, A., Manshouri, T., Parker-Thornburg, J., Rapado, I., Quintas-Cardama, A., Kornblau, S. M., Martinez-Lopez, J., & Post, S. M.
Affiliations: The University of Texas MD Anderson Cancer Center (US)
Hospital Universitario 12 De Octubre (ES)
Corresponding author: Post, Sean M.
ORCID: Gallardo, Miguel
Lee, Hun Ju
Zhang, Xiaorui
Bueso-Ramos, Carlos
Pageon, Laura R.
Multani, Asha
Nazha, Aziz
Manshouri, Taghi
Kornblau, Steven M.
Post, Sean M.
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2015-10
Volume: 28
Issue: 4
Pages: 486-499
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccell.2015.09.001
PMC: PMC4652598
OpenAlex: W2168139795
Cited by: 145
References: 36
Citations by year: 2026: 11 · 2025: 12 · 2024: 4 · 2023: 15 · 2022: 15 · 2021: 21 · 2020: 13 · 2019: 22 · 2018: 14 · 2017: 12 · 2016: 5 · 2015: 1
FWCI: 8.39
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 377 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: University of Texas MD Anderson Cancer Center
National Cancer Institute (P50CA100632, CA-16672, P50 CA1000632-09, P30CA016672)
Topics: Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords: hnRNP K, haploinsufficiency, tumor suppressor, hematologic malignancies, acute myeloid leukemia, chromosome 9 deletion, myeloproliferation, STAT3 signaling, p21, C/EBP, genomic instability, cell proliferation, cell differentiation
MeSH terms: Animals, Cell Differentiation, Cells, Cultured, Chromosomes, Human, Pair 9, Humans, Ribonucleoproteins, Signal Transduction, Gene Expression Regulation, Neoplastic, Survival Analysis, Hematologic Neoplasms, Heterogeneous-Nuclear Ribonucleoprotein K, Chromosomal Instability, Cell Proliferation, Mice, Gene Knockout Techniques, Haploinsufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks